Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation
NCT01232322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 633
Last updated 2013-01-24
Summary
The purpose of this study is to investigate the safety and efficacy for long term treatment of the drug in children aged 6 months and \< 5 years on bronchial asthma in daily clinical usage.
Conditions
- Bronchial Asthma
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Yoshida Shigeru, MD · AstraZeneca
Eligibility
- Min Age
- 6 Months
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
More Related Trials
-
Inhaled Steroid Treatment as Regular Therapy in Early Asthma
NCT00641914 ·Status: COMPLETED ·Phase: PHASE4
-
Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients
NCT00660114 ·Status: COMPLETED
-
A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)
NCT00117338 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma
NCT00504062 ·Status: COMPLETED ·Phase: PHASE3
-
Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children
NCT00641472 ·Status: COMPLETED ·Phase: PHASE4
-
Pulmicort Respules on Relapse Rates After Treatment in the ED
NCT00584636 ·Status: WITHDRAWN ·Phase: PHASE4
-
Some Biomarkers in Bronchial Asthma in Children
NCT04175093 ·Status: UNKNOWN
-
Control of Asthma Patients Symptomatic on Inhaled Corticosteroids
NCT00330070 ·Status: COMPLETED ·Phase: PHASE2
-
New Version Pulmicort Turbuhaler USA Children
NCT00642161 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children
NCT00569192 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia
NCT01326494 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.
NCT00392288 ·Status: COMPLETED ·Phase: PHASE3
-
Determinants Of Oral Corticosteroid Responsiveness in Wheezing Asthmatic Youth
NCT02013076 ·Status: COMPLETED
-
A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children
NCT00624429 ·Status: UNKNOWN ·Phase: PHASE4
-
Asthma in Children
NCT01286532 ·Status: COMPLETED
-
Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
NCT00112411 ·Status: COMPLETED ·Phase: PHASE2
-
Single Dose Oral Dexamethasone Versus Multi-dose Prednisolone in the Treatment of Acute Exacerbations of Asthma in Children
NCT03698630 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma
NCT00509028 ·Status: COMPLETED ·Phase: PHASE3
-
Ex Vivo Pilot Study of the Impact of Nasal Breathing During the Administration of Inhaled Corticosteroids by Inhalation Chamber in Asthmatic Children Ages Between 1 and 4-year-old
NCT03364959 ·Status: TERMINATED ·Phase: NA
-
Low Exhaled NO and ICS in Suspected Asthma
NCT02771717 ·Status: UNKNOWN ·Phase: PHASE4
-
To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.
NCT04848662 ·Status: COMPLETED ·Phase: PHASE1
-
Antibiotics in Infancy--Risk Factor for Childhood Asthma
NCT00037726 ·Status: COMPLETED
-
Long-Term Safety of Symbicort in Asthmatic Children - SAPLING
NCT00646529 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma
NCT01448954 ·Status: COMPLETED ·Phase: PHASE2